XML 21 R11.htm IDEA: XBRL DOCUMENT
v3.22.2

Available for Sale Securities | 6 Months Ended
--- | ---
Jun. 30, 2022
Securities [Abstract] |
AVAILABLE FOR SALE SECURITIES | Note 3 – AVAILABLE FOR SALE Securities The amortized cost and appropriate fair values, together with gross unrealized gains and losses, of securities at June 30, 2022 and December 31, 2021 were as follows:
|  |  |  |  | Gross |  |  | Gross |  |  |  |
($ in thousands) |  | Amortized |  |  | Unrealized |  |  | Unrealized |  |  |  |
|  | Cost |  |  | Gains |  |  | Losses |  |  | Fair Value |
June 30, 2022 |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury and Government agencies |  | $ | 9,056 |  |  | $ | 1 |  |  | $ | (585 | ) |  | $ | 8,472 |
Mortgage-backed securities |  |  | 254,483 |  |  |  | 7 |  |  |  | (25,573 | ) |  |  | 228,917 |
State and political subdivisions |  |  | 13,538 |  |  |  | 24 |  |  |  | (1,345 | ) |  |  | 12,217 |
Other corporate securities |  |  | 17,200 |  |  |  | - |  |  |  | (644 | ) |  |  | 16,556 |
Totals |  | $ | 294,277 |  |  | $ | 32 |  |  | $ | (28,147 | ) |  | $ | 266,162 |
|  |  |  |  | Gross |  |  | Gross |  |  |  |
|  | Amortized |  |  | Unrealized |  |  | Unrealized |  |  |  |
|  | Cost |  |  | Gains |  |  | Losses |  |  | Fair Value |
December 31, 2021 |  |  |  |  |  |  |  |  |  |  |  |
U.S. Treasury and Government agencies |  | $ | 8,986 |  |  | $ | 135 |  |  | $ | (16 | ) |  | $ | 9,105 |
Mortgage-backed securities |  |  | 231,057 |  |  |  | 614 |  |  |  | (3,537 | ) |  |  | 228,134 |
State and political subdivisions |  |  | 12,352 |  |  |  | 536 |  |  |  | (9 | ) |  |  | 12,879 |
Other corporate securities |  |  | 13,200 |  |  |  | 2 |  |  |  | (61 | ) |  |  | 13,141 |
Totals |  | $ | 265,595 |  |  | $ | 1,287 |  |  | $ | (3,623 | ) |  | $ | 263,259 |
The amortized cost and fair value of securities available for sale at June 30, 2022, by contractual maturity, are shown below. Expected maturities will differ from contractual maturities because issuers may have the right to call or prepay obligations with or without call or prepayment penalties.
|  | Amortized |  |  | Fair |
($ in thousands) |  | Cost |  |  | Value |
Within one year |  | $ | 1,256 |  |  | $ | 1,263 |
Due after one year through five years |  |  | 3,089 |  |  |  | 3,037 |
Due after five years through ten years |  |  | 26,189 |  |  |  | 25,005 |
Due after ten years |  |  | 9,260 |  |  |  | 7,940 |
|  |  | 39,794 |  |  |  | 37,245 |
Mortgage-backed securities |  |  | 254,483 |  |  |  | 228,917 |
Totals |  | $ | 294,277 |  |  | $ | 266,162 |
The fair value of securities pledged as collateral, to secure public deposits and for other purposes, was $60.3 million at June 30, 2022 and $54.2 million at December 31, 2021. The fair value of securities delivered for repurchase agreements was $27.5 million at June 30, 2022 and $23.6 million at December 31, 2021. There were no realized gains or losses from sales of available-for-sale securities for the six months ended June 30, 2022 or June 30, 2021. Certain investments in debt securities are reported in the consolidated financial statements at an amount less than their historical cost. Total fair value of these investments was $257.1 million at June 30, 2022, and $214.2 million at December 31, 2021, which consisted of 139 securities, or approximately 97 percent, and 64 securities, or approximately 81 percent, respectively, of the Company’s available-for-sale investment portfolio at such dates. Based on evaluation of available evidence, including recent changes in market interest rates, credit rating information and information obtained from regulatory filings, management believes the declines in fair value for these securities are temporary. Should the impairment of any of these securities become other than temporary, the cost basis of the investment will be reduced and the resulting loss recognized in net income in the period the other-than-temporary impairment is identified. Securities with unrealized losses, aggregated by investment class and length of time that individual securities have been in a continuous unrealized loss position at June 30, 2022 and December 31, 2021, are as follows:
|  | Less than 12 Months |  |  | 12 Months or Longer |  |  | Total |
June 30, 2022 ($ in thousands) |  | Fair Value |  |  | Unrealized Losses |  |  | Fair Value |  |  | Unrealized Losses |  |  | Fair Value |  |  | Unrealized Losses |
U.S. Treasury and Government agencies |  | $ | 7,858 |  |  | $ | (584 | ) |  | $ | 250 |  |  | $ | (1 | ) |  | $ | 8,108 |  |  | $ | (585 | )
Mortgage-backed securities |  |  | 156,242 |  |  |  | (14,928 | ) |  |  | 72,095 |  |  |  | (10,645 | ) |  |  | 228,337 |  |  |  | (25,573 | )
State and political subdivisions |  |  | 9,409 |  |  |  | (1,345 | ) |  |  | - |  |  |  | - |  |  |  | 9,409 |  |  |  | (1,345 | )
Other corporate securities |  |  | 11,206 |  |  |  | (644 | ) |  |  | - |  |  |  | - |  |  |  | 11,206 |  |  |  | (644 | )
Totals |  | $ | 184,715 |  |  | $ | (17,501 | ) |  | $ | 72,345 |  |  | $ | (10,646 | ) |  | $ | 257,060 |  |  | $ | (28,147 | )
|  | Less than 12 Months |  |  | 12 Months or Longer |  |  | Total |
December 31, 2021 |  | Fair Value |  |  | Unrealized Losses |  |  | Fair Value |  |  | Unrealized Losses |  |  | Fair Value |  |  | Unrealized Losses |
U.S. Treasury and Government agencies |  | $ | 3,397 |  |  | $ | (16 | ) |  | $ | - |  |  | $ | - |  |  | $ | 3,397 |  |  | $ | (16 | )
Mortgage-backed securities |  |  | 183,727 |  |  |  | (2,856 | ) |  |  | 18,566 |  |  |  | (681 | ) |  |  | 202,293 |  |  |  | (3,537 | )
State and political subdivisions |  |  | 1,673 |  |  |  | (9 | ) |  |  | - |  |  |  | - |  |  |  | 1,673 |  |  |  | (9 | )
Other corporate securities |  |  | 6,889 |  |  |  | (61 | ) |  |  | - |  |  |  | - |  |  |  | 6,889 |  |  |  | (61 | )
Totals |  | $ | 195,686 |  |  | $ | (2,942 | ) |  | $ | 18,566 |  |  | $ | (681 | ) |  | $ | 214,252 |  |  | $ | (3,623 | )
The total unrealized loss in the securities portfolio was $28.1 million as of June 30, 2022 compared to a $3.6 million unrealized loss at December 31, 2021. Management evaluates securities for other-than-temporary impairment at least on a quarterly basis, and more frequently when economic or market concern warrants such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) the intent of the Company to not sell the investment and whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost. Management has determined there is no other-than-temporary-impairment on its securities as of June 30, 2022.

X
- References No definition available. + Details
Name: | sbfg_SecuritiesAbstract
Namespace Prefix: | sbfg_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Securities. + References No definition available. + Details
Name: | sbfg_SecuritiesTextBlock
Namespace Prefix: | sbfg_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration